166 related articles for article (PubMed ID: 7946563)
1. Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cisplatin in breast and ovarian cancers.
Veneroni S; Zaffaroni N; Daidone MG; Benini E; Villa R; Silvestrini R
Eur J Cancer; 1994; 30A(7):1002-7. PubMed ID: 7946563
[TBL] [Abstract][Full Text] [Related]
2. p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer.
Linn SC; Honkoop AH; Hoekman K; van der Valk P; Pinedo HM; Giaccone G
Br J Cancer; 1996 Jul; 74(1):63-8. PubMed ID: 8679460
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical detection of P-glycoprotein in the management of malignant effusions.
Athanassiadou P; Athanassiades P; Petrakakou E; Zerva C; Mavrikakis M
J Cancer Res Clin Oncol; 1997; 123(8):456-60. PubMed ID: 9292710
[TBL] [Abstract][Full Text] [Related]
4. Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristine.
Sanfilippo O; Ronchi E; De Marco C; Di Fronzo G; Silvestrini R
Eur J Cancer; 1991; 27(2):155-8. PubMed ID: 1673852
[TBL] [Abstract][Full Text] [Related]
5. Alpha-fetoprotein-mediated targeting--a new strategy to overcome multidrug resistance of tumour cells in vitro.
Moskaleva EYu ; Posypanova GA; Shmyrev II; Rodina AV; Muizhnek EL; Severin ES; Katukov VYu ; Luzhkov YM; Severin SE
Cell Biol Int; 1997 Dec; 21(12):793-9. PubMed ID: 9812343
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of homocysteine-induced multidrug resistance of human MCF-7 breast cancer cells and human A2780 ovarian cancer cells.
Lukyanova NY
Exp Oncol; 2010 Mar; 32(1):10-4. PubMed ID: 20332764
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein: the intermediate end point of drug response to induction chemotherapy in locally advanced breast cancer.
Chung HC; Rha SY; Kim JH; Roh JK; Min JS; Lee KS; Kim BS; Lee KB
Breast Cancer Res Treat; 1997 Jan; 42(1):65-72. PubMed ID: 9116319
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo reversal of chemoresistance by tariquidar (XR9576).
Di Nicolantonio F; Knight LA; Glaysher S; Whitehouse PA; Mercer SJ; Sharma S; Mills L; Prin A; Johnson P; Charlton PA; Norris D; Cree IA
Anticancer Drugs; 2004 Oct; 15(9):861-9. PubMed ID: 15457126
[TBL] [Abstract][Full Text] [Related]
9. Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts.
Kolfschoten GM; Hulscher TM; Pinedo HM; Boven E
Br J Cancer; 2000 Oct; 83(7):921-7. PubMed ID: 10970695
[TBL] [Abstract][Full Text] [Related]
10. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y
Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866
[TBL] [Abstract][Full Text] [Related]
11. The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells.
Fu LW; Zhang YM; Liang YJ; Yang XP; Pan QC
Eur J Cancer; 2002 Feb; 38(3):418-26. PubMed ID: 11818209
[TBL] [Abstract][Full Text] [Related]
12. Expression of P-glycoprotein and p53 in advanced hepatocellular carcinoma treated by single agent chemotherapy: clinical correlation.
Chou YY; Cheng AL; Hsu HC
J Gastroenterol Hepatol; 1997 Aug; 12(8):569-75. PubMed ID: 9304508
[TBL] [Abstract][Full Text] [Related]
13. The influence of expression of P-glycoprotein on the penetration of anticancer drugs through multicellular layers.
Tunggal JK; Melo T; Ballinger JR; Tannock IF
Int J Cancer; 2000 Apr; 86(1):101-7. PubMed ID: 10728602
[TBL] [Abstract][Full Text] [Related]
14. Activity of N-benzyl-adriamycin-14-valerate (AD198), a new anthracycline derivate, in multidrug resistant human ovarian and breast carcinoma cell lines.
Harstrick A; Vanhoefer U; Schleucher N; Schroeder J; Baumgart J; Scheulen ME; Wilke H; Seeber S
Anticancer Drugs; 1995 Oct; 6(5):681-5. PubMed ID: 8845478
[TBL] [Abstract][Full Text] [Related]
15.
Jiang B; Yan LJ; Wu Q
DNA Cell Biol; 2019 May; 38(5):485-490. PubMed ID: 30977678
[TBL] [Abstract][Full Text] [Related]
16. Effect of endogenous multidrug resistance 1 and P-glycoprotein expression on anticancer drug resistance in colon cancer cell lines.
Washio I; Nakanishi T; Ishiguro N; Bister B; Tamai I
Biopharm Drug Dispos; 2019 Jan; 40(1):32-43. PubMed ID: 30556139
[TBL] [Abstract][Full Text] [Related]
17. Astragali radix and its main bioactive compounds activate the Nrf2-mediated signaling pathway to induce P-glycoprotein and breast cancer resistance protein.
Lou Y; Guo Z; Zhu Y; Zhang G; Wang Y; Qi X; Lu L; Liu Z; Wu J
J Ethnopharmacol; 2019 Jan; 228():82-91. PubMed ID: 30243825
[TBL] [Abstract][Full Text] [Related]
18. Does P-glycoprotein play a role in clinical resistance of malignant astrocytoma?
Ashmore SM; Thomas DG; Darling JL
Anticancer Drugs; 1999 Nov; 10(10):861-72. PubMed ID: 10630353
[TBL] [Abstract][Full Text] [Related]
19. Multiple drug resistance in the human ovarian carcinoma cell line OAW42-A.
Redmond A; Moran E; Clynes M
Eur J Cancer; 1993; 29A(8):1078-81. PubMed ID: 8100138
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic effect of Jin Long capsule combined with neoadjuvant chemotherapy on invasive breast cancer and the expression change of multidrug resistance proteins].
Yang TY; Yi W; Wen J; Gan CY; Yang YC; Dai M
Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):118-123. PubMed ID: 30862141
[No Abstract] [Full Text] [Related]
[Next] [New Search]
